dihexa cancer risk hgf c met Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cell International c-Met Signaling as a Therapeutic
c Met Signaling as a Therapeutic Target in Head : The Cancer Journal Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress Correlation between hypoxia and HGF c MET expression in the management of pancreatic cancer ScienceDirect dihexa hgf c met cancer risk HGF c MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Growth
Pay in 4 interest-free payments of $5.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30


